Evidence map›Paper›PMID 23086749›Full record

ArticleBlood2012

Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets.

Bjoern F Kraemer, Robert A Campbell, Hansjörg Schwertz, Zechariah G Franks, Adriana Vieira de Abreu, Katharina Grundler, Benjamin T Kile, Bijaya K Dhakal, Matthew T Rondina, Walter H A Kahr and 4 more

Abstract read
In one paragraph

Article in Blood, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Platelet P2YBritish journal of pharmacology · 2024
    Review
  5. Characterization of a Highly VirulentInfection and drug resistance · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. The Immune Nature of Platelets Revisited.Transfusion medicine reviews · 2020
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 5 countries.

Bjoern F KraemerThe Molecular Medicine Program, University of Utah, Salt Lake City, UT 84112, USA.
Robert A Campbell
Hansjörg Schwertz
Zechariah G Franks
Adriana Vieira de Abreu
Katharina Grundler
Benjamin T Kile
Bijaya K Dhakal
Matthew T Rondina
Walter H A Kahr
Matthew A Mulvey
Robert C Blaylock
Guy A Zimmerman
Andrew S Weyrich
University of Utah · USLMU Klinikum · DEUniversity of Toronto · CAWalter and Eliza Hall Institute of Medical Research · AU

Funding

University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
Translational Research Skills Development CoreU54HL112311 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S, ZIMMERMAN, GUY A. · 2012 to 2016
$12.9M
RESEARCH TRAINING IN HEMATOLOGYT32DK007115 · NIDDK · UNIVERSITY OF UTAH · PI LEIBOLD, ELIZABETH ANN, PRCHAL, JOSEF T · 1986 to 2020
$8.4M
TRANSLATIONAL EVENTS IN PLATELETSR01HL066277 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2001 to 2012
$3.8M
Molecular Interactions of Myeloid Cells with EndotheliumR37HL044525 · NHLBI · UNIVERSITY OF UTAH · PI ZIMMERMAN, GUY A. · 2004 to 2013
$3.5M
Bacterial Invasion and Trafficking within the BladderR01AI095647 · NIAID · UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A · 2011 to 2015
$1.8M
Novel Activities of Platelets in Acute Lung InjuryR01HL091754 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2008 to 2011
$1.5M
MOLECULAR INTERACTIONS OF MYELOID CELLS WITH ENDOTHELIUMR01HL044525 · NHLBI · UNIVERSITY OF UTAH · PI ZIMMERMAN, GUY A. · 1990 to 2003
$1.2M
Novel Thrombotic and Inflammatory Activities of Platelets in SepsisR01HL090870 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S, ZIMMERMAN, GUY A. · 2009 to 2010
$1.1M
Novel Platelet Functions in Sepsis and Venous ThromboembolismK23HL092161 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2009 to 2013
$775k
Deciphering ExPEC Virulence MechanismsR21AI090369 · NIAID · UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A · 2011 to 2012
$414k
Control of ExPEC virulence by small RNAsR21AI088086 · NIAID · UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A · 2010 to 2011
$412k
CIHR MOP-81208NCATS NIH HHS UL1 TR001067NHLBI NIH HHS HL44525NHLBI NIH HHS HL66277NHLBI NIH HHS HL90870NHLBI NIH HHS HL91754NHLBI NIH HHS K23 HL092161NHLBI NIH HHS K23 HL92161NHLBI NIH HHS R01 HL044525NHLBI NIH HHS R01 HL066277NHLBI NIH HHS R01 HL090870NHLBI NIH HHS R01 HL091754NHLBI NIH HHS R37 HL044525NHLBI NIH HHS U54 HL112311NHLBI NIH HHS U54HL112311NIAID NIH HHS AI088086NIAID NIH HHS AI090369NIAID NIH HHS AI095647NIAID NIH HHS R01 AI095647NIAID NIH HHS R21 AI088086NIAID NIH HHS R21 AI090369NIA NIH HHS R03 AG040631NIDDK NIH HHS 5T32DK007115-35NIDDK NIH HHS T32 DK007115
6 · The paper itself

Abstract

Bacteria can enter the bloodstream in response to infectious insults. Bacteremia elicits several immune and clinical complications, including thrombocytopenia. A primary cause of thrombocytopenia is shortened survival of platelets. We demonstrate that pathogenic bacteria induce apoptotic events in platelets that include calpain-mediated degradation of Bcl-x(L), an essential regulator of platelet survival. Specifically, bloodstream bacterial isolates from patients with sepsis induce lateral condensation of actin, impair mitochondrial membrane potential, and degrade Bcl-x(L) protein in platelets. Bcl-x(L) protein degradation is enhanced when platelets are exposed to pathogenic Escherichia coli that produce the pore-forming toxin α-hemolysin, a response that is markedly attenuated when the gene is deleted from E coli. We also found that nonpathogenic E coli gain degrading activity when they are forced to express α-hemolysin. Like α-hemolysin, purified α-toxin readily degrades Bcl-x(L) protein in platelets, as do clinical Staphylococcus aureus isolates that produce α-toxin. Inhibition of calpain activity, but not the proteasome, rescues Bcl-x(L) protein degradation in platelets coincubated with pathogenic E coli including α-hemolysin producing strains. This is the first evidence that pathogenic bacteria can trigger activation of the platelet intrinsic apoptosis program and our results suggest a new mechanism by which bacterial pathogens might cause thrombocytopenia in patients with bloodstream infections.

Indexed as

Host-Pathogen InteractionsApoptosisbcl-X ProteinBlood PlateletsCalpainEscherichia coliEscherichia coli InfectionsHumansProteolysisStaphylococcal InfectionsStaphylococcus aureusbcl-X ProteinCalpain

Identifiers

PMID23086749
PMCPMC3525025
OpenAlexW2058931657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.